サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：避妊薬の世界市場規模調査・予測、製品別、流通チャネル別、地域別分析、2022-2029年
市場調査レポート
商品コード
1269610

避妊薬の世界市場規模調査・予測、製品別、流通チャネル別、地域別分析、2022-2029年

Global Contraceptive Drugs Market Size study & Forecast, by Product, by Distribution Channel and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
避妊薬の世界市場規模調査・予測、製品別、流通チャネル別、地域別分析、2022-2029年
出版日: 2023年05月02日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の避妊薬市場は、2021年に約165億9,000万米ドルとなり、予測期間2022-2029年には7.4％以上の健全な成長率で成長すると予測されています。

避妊薬は、女性が出産をコントロールするために消費されるものです。望まない妊娠の増加や性感染症（STD）の流行などの要因により、避妊薬市場は拡大しています。しかし、不妊症の増加や避妊薬・避妊具の使用に伴う副作用は、市場の成長を阻害する可能性があります。

予測期間を通じて、性感染症（STDs）の発生率の上昇と、避妊薬・避妊具に対するアンメットニーズを持つ女性の数の増加が、市場成長を牽引すると予想されます。世界保健機関（WHO）によると、2019年に世界で生殖年齢（15～49歳）の女性約11億人が家族計画を必要としています。そのうち8億4,200万人以上が家族計画のために避妊技術を使用しており、そのうちの2億7,000万人が避妊のニーズが満たされていない状態です。さらに、国連のThe Department of Economic and Social Affairs, Population Division of the United Nationsによると、2019年、世界には生殖年齢（15-49歳）の女性が19億人いると報告されています。約8,000万人が従来の方法を利用し、約8億4,200万人の女性が経口薬や注射薬などの現代的な避妊法を利用しています。また、避妊薬に対する意識の高まりが製品の需要につながり、市場を有利に成長させる要因となっています。また、新興諸国では償還政策が充実しているため、予測期間中の市場導入率が高まると期待されています。

避妊薬の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、その他欧州です。北米は、ブランド製品の優位性とこの地域の疾患有病率の増加により、売上高で市場を独占しています。一方、アジア太平洋は、老年人口や対象人口の増加、バイオシミラー開発のための共同研究の増加、主要企業の地域的拡大、政府機関や非営利団体の市場参入などの要因から、予測期間中に最高のCAGRで成長すると予想されます。

本調査の目的は、近年の異なるセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 避妊薬市場、地域別、2019-2029年
    • 避妊薬市場、製品別、2019-2029年
    • 避妊薬市場、流通チャネル別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 世界の避妊薬市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 避妊薬の世界市場力学

  • 避妊薬市場の影響分析（2019年～2029年）
    • 市場促進要因
      • 政府・NGO別避妊法普及のための取り組み
      • 望まない妊娠の増加
    • 市場の課題
      • 不妊症の有病率の上昇
      • 避妊薬・避妊具の使用に伴う副作用について
    • 市場機会
      • 性感染症（STD）の蔓延化

第4章 避妊薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 避妊薬の世界市場：製品別

  • マーケットスナップショット
  • 避妊薬の世界市場：製品別、実績 - ポテンシャル分析
  • 避妊薬の世界市場製品別推定・予測2019-2029
  • 避妊薬市場、サブセグメント分析
    • オーラル
    • インジェクタブル
    • パッチ

第7章 避妊薬の世界市場：流通チャネル別

  • マーケットスナップショット
  • 避妊薬の世界市場：流通チャネル別、実績 - ポテンシャル分析
  • 避妊薬の世界市場流通チャネル別推定・予測2019-2029
  • 避妊薬市場、サブセグメント分析
    • 病院薬局
    • リテールファーマシー
    • クリニック
    • オンラインチャンネル
    • 公共チャンネル・NGO
    • その他

第8章 避妊薬の世界市場：地域別分析

  • 避妊薬市場、地域別マーケットスナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019年～2029年
      • 流通チャネル別の推定・予測、2019年～2029年
    • カナダ
  • 欧州避妊薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の避妊薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの避妊薬市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Piramal Enterprises Ltd.
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Organon group of companies
    • Johnson & Johnson Services, Inc.
    • AbbVie Inc.
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
    • Amneal Pharmaceuticals, Inc.
    • Bayer AG
    • Agile Therapeutics

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Contraceptive Drugs Market, report scope
  • TABLE 2. Global Contraceptive Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Contraceptive Drugs Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Contraceptive Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 5. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Contraceptive Drugs Market
  • TABLE 70. List of primary sources, used in the study of global Contraceptive Drugs Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Contraceptive Drugs Market, research methodology
  • FIG 2. Global Contraceptive Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Contraceptive Drugs Market, key trends 2021
  • FIG 5. Global Contraceptive Drugs Market, growth prospects 2022-2029
  • FIG 6. Global Contraceptive Drugs Market, porters 5 force model
  • FIG 7. Global Contraceptive Drugs Market, pest analysis
  • FIG 8. Global Contraceptive Drugs Market, value chain analysis
  • FIG 9. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Contraceptive Drugs Market, regional snapshot 2019 & 2029
  • FIG 15. North America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Contraceptive Drugs Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Contraceptive Drugs Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Contraceptive Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Contraceptive Drugs Market is valued approximately USD 16.59 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Contraceptive Drugs are consumed by female for birth control. The Contraceptive Drugs market is expanding because of factors such as increasing prevalence of unwanted pregnancies and increasing prevalence of sexually transmitted diseases (STDs). However, rising prevalence of infertility and adverse effects associated with the use of contraceptive drugs and devices may halt market growth.

Throughout the forecast period, the market growth is anticipated to be driven by the rising incidence of Sexually Transmitted Diseases (STDs) and the rising number of women with unmet need for contraceptive medications & devices. Almost 1.1 billion women worldwide in 2019 who are reproductive age (15 to 49 years) need family planning, according to the World Health Organization. Over 842 million of them use contraceptive techniques for family planning, and 270 million of them have unmet contraception needs. Furthermore, The Department of Economic and Social Affairs, Population Division of the United Nations reports that in 2019 that there are 1.9 billion women in the world who are reproductive age (15-49). Around 80 million people utilize conventional methods, while about 842 million women use contemporary contraception, including oral medications and injectables. In addition, growing awareness regarding contraceptive drugs leads to product demand creating a lucrative growth to the market. Along with these, wide availability of reimbursement policies in developed countries is expected to fuel the market adoption rate in the forecasted period.

The key regions considered for the Global Contraceptive Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

  • Piramal Enterprises Ltd.
  • Organon group of companies
  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • Agile Therapeutics.

Recent Developments in the Market:

  • In February 2020, The U.S. FDA has authorized Agile Therapeutics to commercialize Twirla (levonorgestrel and ethinyl estradiol), a transdermal patch for women.
  • In January 2020, Bayer AG and Dare Bioscience, Inc. have signed a licence agreement to distribute Ovaprene after the U.S. Food and Drug Administration gives the experimental contraception medicine market clearance.

Global Contraceptive Drugs Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Product, Distribution Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Oral
  • Injectable
  • Patches

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channels
  • Public Channels & NGOs
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Contraceptive Drugs Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Contraceptive Drugs Market, by Product, 2019-2029 (USD Billion)
    • 1.2.3. Contraceptive Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Contraceptive Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Contraceptive Drugs Market Dynamics

  • 3.1. Contraceptive Drugs Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Government and NGO initiatives to promote contraceptive methods
      • 3.1.1.2. Increasing prevalence of unwanted pregnancies
    • 3.1.2. Market Challenges
      • 3.1.2.1. Rising prevalence of infertility
      • 3.1.2.2. Adverse effects associated with the use of contraceptive drugs and devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing prevalence of sexually transmitted diseases (STDs)

Chapter 4. Global Contraceptive Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Contraceptive Drugs Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Contraceptive Drugs Market by Product, Performance - Potential Analysis
  • 6.3. Global Contraceptive Drugs Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Contraceptive Drugs Market, Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Injectable
    • 6.4.3. Patches

Chapter 7. Global Contraceptive Drugs Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Contraceptive Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Contraceptive Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 7.4. Contraceptive Drugs Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Clinics
    • 7.4.4. Online Channels
    • 7.4.5. Public Channels & NGOs
    • 7.4.6. Others

Chapter 8. Global Contraceptive Drugs Market, Regional Analysis

  • 8.1. Contraceptive Drugs Market, Regional Market Snapshot
  • 8.2. North America Contraceptive Drugs Market
    • 8.2.1. U.S. Contraceptive Drugs Market
      • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Contraceptive Drugs Market
  • 8.3. Europe Contraceptive Drugs Market Snapshot
    • 8.3.1. U.K. Contraceptive Drugs Market
    • 8.3.2. Germany Contraceptive Drugs Market
    • 8.3.3. France Contraceptive Drugs Market
    • 8.3.4. Spain Contraceptive Drugs Market
    • 8.3.5. Italy Contraceptive Drugs Market
    • 8.3.6. Rest of Europe Contraceptive Drugs Market
  • 8.4. Asia-Pacific Contraceptive Drugs Market Snapshot
    • 8.4.1. China Contraceptive Drugs Market
    • 8.4.2. India Contraceptive Drugs Market
    • 8.4.3. Japan Contraceptive Drugs Market
    • 8.4.4. Australia Contraceptive Drugs Market
    • 8.4.5. South Korea Contraceptive Drugs Market
    • 8.4.6. Rest of Asia Pacific Contraceptive Drugs Market
  • 8.5. Latin America Contraceptive Drugs Market Snapshot
    • 8.5.1. Brazil Contraceptive Drugs Market
    • 8.5.2. Mexico Contraceptive Drugs Market
    • 8.5.3. Rest of Latin America Contraceptive Drugs Market
  • 8.6. Rest of The World Contraceptive Drugs Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Piramal Enterprises Ltd.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Organon group of companies
    • 9.2.3. Johnson & Johnson Services, Inc.
    • 9.2.4. AbbVie Inc.
    • 9.2.5. Pfizer Inc.
    • 9.2.6. Teva Pharmaceutical Industries Ltd.
    • 9.2.7. Viatris Inc.
    • 9.2.8. Amneal Pharmaceuticals, Inc.
    • 9.2.9. Bayer AG
    • 9.2.10. Agile Therapeutics

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption